May 2025
1. WANG P, Zhang Y, Giovannucci EL
   Dietary context in the association between red meat consumption and risk of type 2 diabetes.
   Metabolism. 2025;169:156277.
   

   >> Share

   
   April 2025
2. WU H, Yang Z, Zhou T, Wang J, et al
   UBC9 ameliorates diabetic cardiomyopathy by modulating cardiomyocyte mitophagy through NEDD4/RUNX2/PSEN2 axis.
   Metabolism. 2025 Apr 8:156264. doi: 10.1016/j.metabol.2025.156264.
   

   >> Share

   
   
3. ZHONG Y, Wei J, Jiang R
   Revisiting gender differences in obesity and type 2 diabetes: Letter to the editor.
   Metabolism. 2025 Apr 3:156260. doi: 10.1016/j.metabol.2025.156260.
   

   >> Share

   
   March 2025
4. MOLDOVAN RA, Hidalgo MR, Castane H, Jimenez-Franco A, et al
   Landscape of sex differences in obesity and type 2 diabetes in subcutaneous adipose tissue: a systematic review and meta-analysis of transcriptomics studies.
   Metabolism. 2025 Mar 27:156241. doi: 10.1016/j.metabol.2025.156241.
   

   >> Share

   
   
5. BHOWMICK DC, Ahn M, Bhattacharya S, Aslamy A, et al
   DOC2b enrichment mitigates proinflammatory cytokine-induced CXCL10 expression by attenuating IKKbeta and STAT-1 signaling in human islets.
   Metabolism. 2025;164:156132.
   

   >> Share

   
   
6. KARAKASIS P, Patoulias D, Fragakis N, Mantzoros CS, et al
   Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis.
   Metabolism. 2025;164:156113.
   

   >> Share

   
   February 2025
7. SCHORK A, Fritsche A, Schleicher ED, Peter A, et al
   Differential risk assessment in persons at risk of type 2 diabetes using urinary peptidomics.
   Metabolism. 2025;167:156174.
   

   >> Share

   
   
8. HUANG J
   A systematic review & updated meta-analysis on the association between higher consumption of ultra processed foods and risk of diabetes and its complications: Letter to the editor.
   Metabolism. 2025 Feb 11:156156. doi: 10.1016/j.metabol.2025.156156.
   

   >> Share

   
   
9. SOUZA M, Moura FS, Lima LCV, Amaral MJM, et al
   A systematic review & updated meta-analysis on the association between higher consumption of ultra processed foods and risk of diabetes and its complications: Response letter.
   Metabolism. 2025 Feb 11:156155. doi: 10.1016/j.metabol.2025.156155.
   

   >> Share

   
   
10. CHEN J, Luo M, Xing Z, Chen Y, et al
    Start small, think big: MicroRNAs in diabetes mellitus and relevant cardiorenal-liver metabolic health spectrum.
    Metabolism. 2025 Feb 4:156153. doi: 10.1016/j.metabol.2025.156153.
    

    >> Share

    
    
11. MEZZA T, Wewer Albrechtsen NJ, Di Giuseppe G, Ferraro PM, et al
    Human subjects with impaired beta-cell function and glucose tolerance have higher levels of intra-islet intact GLP-1.
    Metabolism. 2025;163:156087.
    

    >> Share

    
    
12. KOKKORAKIS M, Folkertsma P, Forte JC, Wolffenbuttel BHR, et al
    GDF-15 improves the predictive capacity of steatotic liver disease non-invasive tests for incident morbidity and mortality risk for cardio-renal-metabolic diseases and malignancies.
    Metabolism. 2025;163:156047.
    

    >> Share

    
    January 2025
13. SOUZA M, Moura FS, Lima LCV, Amaral MJM, et al
    Association between higher consumption of ultra-processed foods and risk of diabetes and its complications: A systematic review & updated meta-analysis.
    Metabolism. 2025 Jan 21:156134. doi: 10.1016/j.metabol.2025.156134.
    

    >> Share

    
    
14. LUO YY, Ruan CS, Zhao FZ, Yang M, et al
    ZBED3 exacerbates hyperglycemia by promoting hepatic gluconeogenesis through CREB signaling.
    Metabolism. 2025;162:156049.
    

    >> Share

    
    
15. DENG X, Tang C, Fang T, Li T, et al
    Disruption of branched-chain amino acid homeostasis promotes the progression of DKD via enhancing inflammation and fibrosis-associated epithelial-mesenchymal transition.
    Metabolism. 2025;162:156037.
    

    >> Share

    
    December 2024
16. DOU C, Liu D, Kong L, Chen M, et al
    Shared genetic architecture of type 2 diabetes with muscle mass and function and frailty reveals comorbidity etiology and pleiotropic druggable targets.
    Metabolism. 2024 Dec 20:156112. doi: 10.1016/j.metabol.2024.156112.
    

    >> Share

    
    
17. KIM JS, Jun JH, Lee J, Park S, et al
    HDAC6 mediates NLRP3 inflammasome activation in the pathogenesis of diabetic retinopathy.
    Metabolism. 2024 Dec 15:156108. doi: 10.1016/j.metabol.2024.156108.
    

    >> Share

    
    November 2024
18. WU Q, Zeng Y, Geng K, Guo M, et al
    The role of IL-1 family cytokines in diabetic cardiomyopathy.
    Metabolism. 2024 Nov 25:156083. doi: 10.1016/j.metabol.2024.156083.
    

    >> Share

    
    
19. CONGUR I, Mingrone G, Guan K
    Targeting endoplasmic reticulum stress as a potential therapeutic strategy for diabetic cardiomyopathy.
    Metabolism. 2024 Nov 6:156062. doi: 10.1016/j.metabol.2024.156062.
    

    >> Share

    
    
20. ZHANG H, Zhou XD, Shapiro MD, Lip GYH, et al
    Global burden of metabolic diseases, 1990-2021.
    Metabolism. 2024;160:155999.
    

    >> Share

    
    August 2024
21. MISHRA RC, Belke DD, Singh L, Wulff H, et al
    Targeting endothelial K(Ca) channels in vivo restores arterial and endothelial function in type 2 diabetic rats.
    Metabolism. 2024 Aug 18:156001. doi: 10.1016/j.metabol.2024.156001.
    

    >> Share

    
    
22. ROSELL-DIAZ M, Petit-Gay A, Molas-Prat C, Gallardo-Nuell L, et al
    Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men.
    Metabolism. 2024;157:155941.
    

    >> Share

    
    
23. CAI Z, Yang Y, Zhong J, Ji Y, et al
    cGAS suppresses beta-cell proliferation by a STING-independent but CEBPbeta-dependent mechanism.
    Metabolism. 2024;157:155933.
    

    >> Share

    
    July 2024
24. KANG JS, Cho NJ, Lee SW, Lee JG, et al
    RIPK3 causes mitochondrial dysfunction and albuminuria in diabetic podocytopathy through PGAM5-Drp1 signaling.
    Metabolism. 2024 Jul 30:155982. doi: 10.1016/j.metabol.2024.155982.
    

    >> Share

    
    
25. SHU S, Cui H, Liu Z, Zhang H, et al
    Suppression of RCAN1 alleviated lipid accumulation and mitochondrial fission in diabetic cardiomyopathy.
    Metabolism. 2024 Jul 23:155977. doi: 10.1016/j.metabol.2024.155977.
    

    >> Share

    
    
26. ZHAO M, Shen Z, Zheng Z, Xu Y, et al
    Cardiomyocyte LGR6 alleviates ferroptosis in diabetic cardiomyopathy via regulating mitochondrial biogenesis.
    Metabolism. 2024 Jul 20:155979. doi: 10.1016/j.metabol.2024.155979.
    

    >> Share

    
    
27. RICHTER MM, Kemp IM, Heeboll S, Winther-Sorensen M, et al
    Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms.
    Metabolism. 2024;156:155915.
    

    >> Share

    
    June 2024
28. HANDELSMAN Y, Anderson JE, Bakris GL, Ballantyne CM, et al
    DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases.
    Metabolism. 2024 Jun 4:155931. doi: 10.1016/j.metabol.2024.155931.
    

    >> Share

    
    
29. SABATINI S, Nolan JJ, O'Donoghue G, Kennedy A, et al
    Baseline phenotypes with preserved beta-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies.
    Metabolism. 2024;155:155910.
    

    >> Share

    
    May 2024
30. HUTTASCH M, Roden M, Kahl S
    Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
    Metabolism. 2024 May 21:155937. doi: 10.1016/j.metabol.2024.155937.
    

    >> Share

    
    
31. LIAN LY, Targher G, Byrne CD, Liu WY, et al
    Resmetirom for MASH patients with diabetes: challenges and opportunities in the real world.
    Metabolism. 2024 May 15:155935. doi: 10.1016/j.metabol.2024.155935.
    

    >> Share

    
    April 2024
32. JEREMIAH SS, Moin ASM, Butler AE
    Virus-induced diabetes mellitus, revisiting infection etiology in light of SARS-CoV-2.
    Metabolism. 2024 Apr 18:155917. doi: 10.1016/j.metabol.2024.155917.
    

    >> Share

    
    
33. ROSENDO-SILVA D, Gomes PB, Rodrigues T, Viana S, et al
    Clinical and molecular profiling of human visceral adipose tissue reveals impairment of vascular architecture and remodeling as an early hallmark of dysfunction.
    Metabolism. 2024;153:155788.
    

    >> Share

    
    March 2024
34. HE Y, Qu L
    The role and mechanisms of non-coding RNAs in diabetic peripheral neuropathy.
    Metabolism. 2024 Mar 8:155833. doi: 10.1016/j.metabol.2024.155833.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share